Haemonetics Automated Cell Processor ACP™ 215

País: Cingapura

Língua: inglês

Origem: HSA (Health Sciences Authority)

Disponível em:

Transmedic Pte Ltd

Classe:

Class C medical device

Fabricado por:

Haemonetics Corporation

Área terapêutica:

Hematology

Indicações terapêuticas:

The ACP 215 system can perform the following types of procedures: •Prepare collected red blood cell products with glycerol for freezing. •Deglycerolize thawed red blood cell products, removing extra cellular components, and re-suspend the red blood cells in an additive solution. •Wash red blood cell units stored in commonly used AC and additive solutions to remove plasma and extra cellular components. The ability to process-control the addition and removal of cryroprotectant solution as well as wash banked blood in a closed system significantly improves the safety and availability of blood products.

Resumo do produto:

Models: ACP215 - 02215-220-E, RBC De-Glycerol. Sets 325mL BMB - 00236-00, RBC De-Glycerol. / Cell Wash Sets - 00235-00/235, RBC Glycerolization Sets - 00225-00/225, Additive Solution Formula 3 (AS-3), 300 mL - 0462A-00, Sodium Chloride 12% 100 ml - TSCS1201GOO (SOL.IPERT.100M1), Sodium Chloride 12% 100 ml - TSCS1201GOO (SOL.IPERT.100M2), Glucose 0.2% Sodium Chloride 0.9% 2000 ml - TMIS0220GOO (SOL.FIS.2000M)

Data de autorização:

2010-07-28